| |
| |
|
| Insider
Information: |
Broadfin Capital, Llc |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
23,109,447 |
|
|
Indirect Shares
|
4,278,819 |
|
|
| Direct
Value |
$59,416,585 |
|
|
|
Indirect Value
|
$23,918,598 |
|
|
| Total
Shares |
27,388,266 |
|
|
| Total
Value |
$83,335,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Societal CDMO, Inc |
SCTL |
10% Owner |
2014-09-05 |
1,172,195 |
|
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2016-09-13 |
4,361,291 |
2016-09-13 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
10% Owner |
2017-01-03 |
0 |
2017-01-03 |
0 |
Premium* |
|
|
Progenics Pharmaceuticals Inc |
PGNX |
10% Owner |
2017-01-11 |
7,951,169 |
2017-01-11 |
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2017-05-19 |
5,184,942 |
2017-05-19 |
0 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2017-05-25 |
4,436,726 |
|
0 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2018-08-14 |
3,124 |
2018-08-14 |
4,278,819 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2018-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,124 |
3,124 |
0 |
- |
|
| CORI |
Corium International, Inc... |
10% Owner |
– – • |
2017-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,436,726 |
|
- |
|
| PETX |
Aratana Therapeutics, Inc... |
10% Owner |
– – • |
2017-05-19 |
4 |
OE |
$7.50 |
$5,471,250 |
D/D |
729,500 |
5,184,942 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
10% Owner |
– – • |
2017-01-11 |
4 |
D |
$8.95 |
$8,950,000 |
D/D |
(1,000,000) |
7,951,169 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
10% Owner |
– – • |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,394,464) |
0 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
10% Owner |
– – • |
2017-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,394,464 |
|
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2016-09-13 |
4 |
B |
$1.75 |
$131,250 |
D/D |
75,000 |
4,361,291 |
2.45 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2014-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,172,195 |
|
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
